RxDoctor Payments Data

Jeffrey Karr, DPM

Podiatrist · Lakeland, FLNPI 1013988658

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (56.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Bone Support Inc. at 38.7% of the total. Reporting peaked in 2023 at $39,583 and has fallen 89.0% since, to $4,352 in 2025. Among podiatrist clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$100,806in general payments, 2019–2025

Across 174 payments — averaging $579.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bone Support Inc.$39K
  • Organogenesis Inc.$35K
  • Smith+Nephew$19K
  • Osteonovus, Inc.$5K
  • Paratek Pharmaceuticals, Inc.$1K
  • Inari Medical, Inc.$500
  • plus $462 from 6 others

What the payments were for

  • Consulting fees$56,47756%
  • Speaking & faculty fees$32,14632%
  • Travel & lodging$7,5708%
  • Food & beverage$4,5915%
  • Education$220%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$100,806 in reported general payments places this provider in the 95th percentile of 588 podiatrist providers in Florida.

See all podiatrist providers in Florida

Medicare billing

Part B allowed, 2024
$150,542
Medicare patients
205
Services billed
1,825

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gentamicin Sulfate76$4,049
Pregabalin126$3,335
Pentoxifylline106$2,733
Celecoxib57$1,390
Methylprednisolone139$1,165
Ciprofloxacin Hcl93$1,045
Meloxicam218$1,023
Piroxicam18$856
Terbinafine Hcl31$821
Doxycycline Monohydrate45$654
Gabapentin18$322
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav19$296
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim47$279
Doxycycline Hyclate14$122
Clindamycin Hcl17$114

Paid to pharmacies, not to this prescriber.

Other podiatrist in Lakeland

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →